Adage Capital Partners Gp, L.L.C. Oric Pharmaceuticals, Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $56.4 Billion
- Q2 2025
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 365,400 shares of ORIC stock, worth $5.25 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
365,400Holding current value
$5.25 Million% of portfolio
0.01%Shares
5 transactions
Others Institutions Holding ORIC
# of Institutions
146Shares Held
91.8MCall Options Held
1.03MPut Options Held
10.1K-
Nextech Invest, Ltd. Zurich, V87.16MShares$103 Million13.76% of portfolio
-
Vr Adviser, LLC New York, NY6.6MShares$94.9 Million13.26% of portfolio
-
Viking Global Investors LP6.57MShares$94.5 Million0.21% of portfolio
-
Nextech Invest Ag5.29MShares$76 Million7.95% of portfolio
-
Black Rock Inc. New York, NY4.83MShares$69.5 Million0.0% of portfolio
About Oric Pharmaceuticals, Inc.
- Ticker ORIC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,576,700
- Market Cap $569M
- Description
- ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...